A study protocol for facility assessment and follow-up evaluations of the barriers to access, availability, utilization and readiness of contraception, abortion and postabortion services in Zika affected areas.
BACKGROUND
The Zika virus epidemic in Latin America has elicited official recommendations for women to delay or avoid pregnancy in affected countries, which has increased demand for family planning services. It is likely, however, that health facilities in areas where the population is most vulnerable to the disease lack the capacity to respond to the increased demand for family planning services. Our objectives are to perform facilities assessment and understand client perceptions in areas affected by Zika virus, and to track changes in these parameters over time.


METHODS
We will collaborate with local health authorities to map facilities that have the capacity to provide services in contraception and safe abortion, including induced abortion to the full extent of the law and post-abortion care for treatment of complications from unsafe abortion and post-abortion contraception. We then will carry out a survey of facilities to assess the availability of services and their readiness to provide contraception and safe abortion care. All facilities will be assessed for baseline readiness and availability of services, and a random subsample of surveyed facilities will be reassessed in second and third rounds of surveys. Focus group interviews with clients will be conducted as part of the facilities surveys in order to gain an understanding of the community's knowledge, needs and perceived barriers to healthcare in the context of the Zika virus epidemic.


CONCLUSIONS
The findings of this study will aid the response to Zika virus ranging from the identification of healthcare facilities that can be potentially strengthened, to the formulation of interventions to reduce barriers and improve readiness of facilities to provide contraception and safe abortion services. Lessons learned from this study will help to build and strengthen health systems that are more prepared to consistently providing reproductive healthcare services in the context of health emergencies.
Department of Reproductive Health and Research, World Health Organization, Avenue Appia 20, Geneva 27, CH-1211, Switzerland. alimoa@who.int.
Moazzam
M
Ali
Department of Reproductive Health and Research, World Health Organization, Avenue Appia 20, Geneva 27, CH-1211, Switzerland.
Rachel
R
Folz
Department of Reproductive Health and Research, World Health Organization, Avenue Appia 20, Geneva 27, CH-1211, Switzerland.
Kelsey
K
Miller
Department of Reproductive Health and Research, World Health Organization, Avenue Appia 20, Geneva 27, CH-1211, Switzerland.
Brooke Ronald
BR
Johnson
Department of Reproductive Health and Research, World Health Organization, Avenue Appia 20, Geneva 27, CH-1211, Switzerland.
James
J
Kiarie
D000028:Abortion, Induced / Q000379:methods*; D000359:Aftercare / Q000592:standards*; D003267:Contraception / Q000379:methods*; D005193:Family Planning Services / Q000458:organization & administration*; D005260:Female; D005500:Follow-Up Studies; D006297:Health Services Accessibility; D006801:Humans; D010342:Patient Acceptance of Health Care; D011247:Pregnancy; D034121:Reproductive Health Services / Q000458:organization & administration*; D000071244:Zika Virus; D000071243:Zika Virus Infection / Q000453:epidemiology / Q000517:prevention & control
Abortion care; Contraception; Health facilities; Latin America; Post-abortion care; Rapid assessment; Zika virus